Europe Immunoassay Analyzers Market Size & Outlook
Europe immunoassay analyzers market, 2016-2028 (US$M)
Related Markets
Europe immunoassay analyzers market highlights
- The Europe immunoassay analyzers market generated a revenue of USD 6,390.1 million in 2021.
- The market is expected to grow at a CAGR of 6.4% from 2022 to 2028.
- In terms of segment, reagents & kits was the largest revenue generating product in 2021.
- Reagents & Kits is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2022 to 2028.
Europe data book summary
| Market revenue in 2021 | USD 6,390.1 million |
| Market revenue in 2028 | USD 9,875.9 million |
| Growth rate | 6.4% (CAGR from 2021 to 2028) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & Kits |
| Historical data covered | 2016 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents & Kits, Analyzers/Instruments, Software & Services |
| Key market players worldwide | BioMerieux SA, Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Becton Dickinson & Co, Bio-Rad Laboratories Inc Class A, Beckman Coulter |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.5% of the global immunoassay analyzers market in 2021.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 9,589.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunoassay Analyzers Market Scope
Immunoassay Analyzers Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe immunoassay analyzers market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay analyzers market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 66.33% in 2021. Horizon Databook has segmented the Europe immunoassay analyzers market based on reagents & kits, analyzers/instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
In 2020, Europe accounted for the second-largest market share in global immunoassay analyzers market. The prevalence of Noncommunicable Diseases (NCDs) and associated mortality is increasing in the region.
Cancer, cardiovascular diseases, and chronic respiratory diseases are some of the leading causes of death and disability in the region. Increasing proportion of children and adults are living with obesity, which is considered one of the primary risk factors for NCDs.
According to WHO, NCDs accounts for an estimated 77% of the disease burden and 86% of the deaths in this region. Adhering to effective prevention and control measures of NCDs has become crucial during the ongoing pandemic, since NCDs are major risk factors for patients suffering from COVID-19.
Reasons to subscribe to Europe immunoassay analyzers market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe immunoassay analyzers market databook
-
Our clientele includes a mix of immunoassay analyzers market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe immunoassay analyzers market , including forecasts for subscribers. This continent databook contains high-level insights into Europe immunoassay analyzers market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Europe immunoassay analyzers market size, by country, 2016-2028 (US$M)
Europe Immunoassay Analyzers Market Outlook Share, 2021 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
